首页 > 最新文献

JCO Global Oncology最新文献

英文 中文
Erratum: Patient-Reported Outcomes Improve Following Mastectomy for Early-Stage Breast Cancer in Nigeria: Pilot Experience Using a Translated and Validated BREAST-Q. 勘误:尼日利亚早期乳腺癌乳房切除术后患者报告结果有所改善:使用经过翻译和验证的 BREAST-Q 的试点经验。
IF 3.2 Q2 ONCOLOGY Pub Date : 2024-08-01 DOI: 10.1200/GO-24-00369
{"title":"Erratum: Patient-Reported Outcomes Improve Following Mastectomy for Early-Stage Breast Cancer in Nigeria: Pilot Experience Using a Translated and Validated BREAST-Q.","authors":"","doi":"10.1200/GO-24-00369","DOIUrl":"https://doi.org/10.1200/GO-24-00369","url":null,"abstract":"","PeriodicalId":14806,"journal":{"name":"JCO Global Oncology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142080342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Age-Stratified Assessment of the Impact of Breast Cancer Knowledge on the Lifestyle and Dietary Patterns Among Nigerian Females. 分年龄评估乳腺癌知识对尼日利亚女性生活方式和饮食模式的影响
IF 3.2 Q2 ONCOLOGY Pub Date : 2024-08-01 DOI: 10.1200/GO.24.00178
Magdalene Eno Effiong, Israel Sunmola Afolabi, Shalom Nwodo Chinedu

Purpose: Breast cancer (BC) is a major cause of cancer-related mortality in Nigeria, which is exacerbated by a lack of understanding of how knowledge of BC risk factors influences the lifestyle and dietary patterns of Nigerians across age groups. This study evaluated the influence of knowledge of BC risks on lifestyle and dietary patterns across age groups, aiming to inform early management, prevention, and survival rates.

Methods: A cross-sectional survey was conducted in Ota, Ado-odo, Ogun State, Nigeria, involving participants from six educational institutions. The study assessed knowledge of BC risks factors and lifestyle/dietary habits using questionnaires. Results were analyzed using Epi Info software and SPSS version 20.

Results: The participants' age ranged from 13 to 60 years, with a mean of 21 years. The age categories of the participants were 75.24% adolescents (13-19), 18.68% young adults (20-40), and 6.08% middle-aged (41-60). Middle-aged individuals had the least knowledge about smoking (7.58%), alcohol (26.09%), antibiotics (7.25%), and red meat/smoked foods (20.09%), which translated into their poor dietary/lifestyle patterns. Young adults showed profound physical inactivity (71.00%), while adolescents consumed more carbonated drinks (71.53%), which corresponded to lack of knowledge about the effects of physical inactivity (10.85%) and consumption of carbonated drinks (13.70%) on BC risk.

Conclusion: The study found that understanding BC risk factors directly affects lifestyle and dietary patterns. Age groups with higher knowledge had better lifestyle/dietary patterns. This highlights the need for a tailored intervention on lifestyle and dietary education across all age groups, especially the middle-aged, so as to inform a deliberate adjustment in lifestyle and dietary habits, which play crucial roles in BC incidence, survival, and prevention.

目的:在尼日利亚,乳腺癌(BC)是导致癌症相关死亡的一个主要原因,而对乳腺癌风险因素的了解如何影响不同年龄段尼日利亚人的生活方式和饮食模式缺乏了解则加剧了这一问题。本研究评估了不同年龄组的人对乳腺癌风险知识对生活方式和饮食模式的影响,旨在为早期管理、预防和存活率提供信息:在尼日利亚奥贡州奥塔、阿多阿多进行了一项横断面调查,参与者来自六所教育机构。研究采用问卷调查的方式,评估了对乳腺癌风险因素和生活方式/饮食习惯的了解程度。研究结果使用 Epi Info 软件和 SPSS 20 版本进行分析:参与者的年龄从 13 岁到 60 岁不等,平均年龄为 21 岁。参与者的年龄分布为:青少年(13-19 岁)占 75.24%,青年(20-40 岁)占 18.68%,中年(41-60 岁)占 6.08%。中年人对吸烟(7.58%)、饮酒(26.09%)、抗生素(7.25%)和红肉/熏制食品(20.09%)的了解最少,这反映出他们的饮食/生活方式不佳。青壮年表现出极度缺乏运动(71.00%),而青少年则饮用更多碳酸饮料(71.53%),这与缺乏运动(10.85%)和饮用碳酸饮料(13.70%)对乳腺癌风险的影响的知识相对应:研究发现,对乳腺癌风险因素的了解会直接影响生活方式和饮食模式。知识水平较高的年龄组有更好的生活方式/饮食模式。这突出表明,有必要对所有年龄组(尤其是中年人)的生活方式和饮食教育进行有针对性的干预,以便有意识地调整生活方式和饮食习惯,这对乳腺癌的发病、存活和预防至关重要。
{"title":"Age-Stratified Assessment of the Impact of Breast Cancer Knowledge on the Lifestyle and Dietary Patterns Among Nigerian Females.","authors":"Magdalene Eno Effiong, Israel Sunmola Afolabi, Shalom Nwodo Chinedu","doi":"10.1200/GO.24.00178","DOIUrl":"10.1200/GO.24.00178","url":null,"abstract":"<p><strong>Purpose: </strong>Breast cancer (BC) is a major cause of cancer-related mortality in Nigeria, which is exacerbated by a lack of understanding of how knowledge of BC risk factors influences the lifestyle and dietary patterns of Nigerians across age groups. This study evaluated the influence of knowledge of BC risks on lifestyle and dietary patterns across age groups, aiming to inform early management, prevention, and survival rates.</p><p><strong>Methods: </strong>A cross-sectional survey was conducted in Ota, Ado-odo, Ogun State, Nigeria, involving participants from six educational institutions. The study assessed knowledge of BC risks factors and lifestyle/dietary habits using questionnaires. Results were analyzed using Epi Info software and SPSS version 20.</p><p><strong>Results: </strong>The participants' age ranged from 13 to 60 years, with a mean of 21 years. The age categories of the participants were 75.24% adolescents (13-19), 18.68% young adults (20-40), and 6.08% middle-aged (41-60). Middle-aged individuals had the least knowledge about smoking (7.58%), alcohol (26.09%), antibiotics (7.25%), and red meat/smoked foods (20.09%), which translated into their poor dietary/lifestyle patterns. Young adults showed profound physical inactivity (71.00%), while adolescents consumed more carbonated drinks (71.53%), which corresponded to lack of knowledge about the effects of physical inactivity (10.85%) and consumption of carbonated drinks (13.70%) on BC risk.</p><p><strong>Conclusion: </strong>The study found that understanding BC risk factors directly affects lifestyle and dietary patterns. Age groups with higher knowledge had better lifestyle/dietary patterns. This highlights the need for a tailored intervention on lifestyle and dietary education across all age groups, especially the middle-aged, so as to inform a deliberate adjustment in lifestyle and dietary habits, which play crucial roles in BC incidence, survival, and prevention.</p>","PeriodicalId":14806,"journal":{"name":"JCO Global Oncology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142004277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quality of Life Gain Following Treatment Among Breast Cancer Survivors With and Without HIV. 感染和未感染艾滋病毒的乳腺癌幸存者在治疗后生活质量的提高。
IF 3.2 Q2 ONCOLOGY Pub Date : 2024-08-01 DOI: 10.1200/GO.24.00110
Michael P Dykstra, Katrin S Sadigh, Isaac Nkele, Memory Bvochora-Nsingo, Yehoda M Martei, James Wester, Kutlo Manyake, Jason A Efstathiou, Peter Vuylsteke, Neo M Tapela, Scott Dryden-Peterson

Purpose: Women living with HIV (WLWH) experience decreased breast cancer survival. We sought to determine whether WLWH surviving breast cancer also experienced different quality of life (QOL) gain.

Methods: Women who enrolled in the Thabatse Cancer Cohort across oncology centers in Botswana for the initial treatment of stage I-III breast cancer from October 2010 to February 2022 were included. Exclusion criteria were no documented definitive therapy and incomplete data at treatment end or 24 ± 3 months after treatment. QOL was measured quarterly using the SF-8 questionnaire. G methods using weighted exposure and outcome modules were used to mitigate potential bias from imbalances in demographic and cancer characteristics by HIV status. Primary analysis was change in physical component summary (PCS) and mental component summary (MCS) from treatment end to 24 months after treatment for WLWH compared with women without HIV.

Results: Of 603 women enrolled, the final analysis included 298, comprising 85 WLWH and 213 women without HIV. Most common reasons for exclusion were no documented definitive treatment (n = 114) and death before 21 months after treatment (n = 137). WLWH were younger, were less wealthy, and had more estrogen receptor/progesterone receptor positive tumors. Overall, PCS and MCS significantly increased from treatment end to 24 months after treatment, from 50.8 to 52.8 and 51.8 to 53.7, respectively. There was no difference in the change of the PCS or MCS with HIV infection, 2.2 (95% CI, -0.4 to 4.9) and 0.6 (95% CI, -1.7 to 2.9), respectively.

Conclusion: HIV infection did not impede QOL gain at 24 months after treatment in women surviving breast cancer. Further work is needed to clarify the role of HIV on specific treatment-related morbidities and in other malignancies.

目的:感染艾滋病毒的女性(WLWH)的乳腺癌存活率较低。我们试图确定乳腺癌存活的女性艾滋病感染者是否也会获得不同的生活质量(QOL):方法:纳入 2010 年 10 月至 2022 年 2 月期间在博茨瓦纳各肿瘤中心接受 I-III 期乳腺癌初始治疗的 Thabatse 癌症队列妇女。排除标准为无明确治疗记录、治疗结束时或治疗后 24 ± 3 个月内数据不完整。使用 SF-8 问卷每季度测量一次 QOL。采用加权暴露和结果模块的 G 方法,以减轻因艾滋病病毒感染状况造成的人口统计学和癌症特征不平衡而产生的潜在偏差。主要分析指标是 WLWH 妇女与未感染 HIV 妇女相比,从治疗结束到治疗后 24 个月期间身体成分总表(PCS)和精神成分总表(MCS)的变化情况:在 603 名注册妇女中,最终分析包括 298 人,其中包括 85 名 WLWH 妇女和 213 名未感染 HIV 的妇女。最常见的排除原因是无明确治疗记录(114 人)和治疗后 21 个月前死亡(137 人)。WLWH 更年轻,更不富裕,雌激素受体/孕激素受体阳性肿瘤更多。总体而言,从治疗结束到治疗后 24 个月,PCS 和 MCS 显著增加,分别从 50.8 增加到 52.8 和 51.8 增加到 53.7。感染艾滋病病毒后,PCS和MCS的变化没有差异,分别为2.2(95% CI,-0.4至4.9)和0.6(95% CI,-1.7至2.9):结论:HIV 感染并不妨碍乳腺癌女性患者在治疗后 24 个月获得 QOL。还需要进一步研究艾滋病毒对特定治疗相关疾病和其他恶性肿瘤的影响。
{"title":"Quality of Life Gain Following Treatment Among Breast Cancer Survivors With and Without HIV.","authors":"Michael P Dykstra, Katrin S Sadigh, Isaac Nkele, Memory Bvochora-Nsingo, Yehoda M Martei, James Wester, Kutlo Manyake, Jason A Efstathiou, Peter Vuylsteke, Neo M Tapela, Scott Dryden-Peterson","doi":"10.1200/GO.24.00110","DOIUrl":"10.1200/GO.24.00110","url":null,"abstract":"<p><strong>Purpose: </strong>Women living with HIV (WLWH) experience decreased breast cancer survival. We sought to determine whether WLWH surviving breast cancer also experienced different quality of life (QOL) gain.</p><p><strong>Methods: </strong>Women who enrolled in the Thabatse Cancer Cohort across oncology centers in Botswana for the initial treatment of stage I-III breast cancer from October 2010 to February 2022 were included. Exclusion criteria were no documented definitive therapy and incomplete data at treatment end or 24 ± 3 months after treatment. QOL was measured quarterly using the SF-8 questionnaire. G methods using weighted exposure and outcome modules were used to mitigate potential bias from imbalances in demographic and cancer characteristics by HIV status. Primary analysis was change in physical component summary (PCS) and mental component summary (MCS) from treatment end to 24 months after treatment for WLWH compared with women without HIV.</p><p><strong>Results: </strong>Of 603 women enrolled, the final analysis included 298, comprising 85 WLWH and 213 women without HIV. Most common reasons for exclusion were no documented definitive treatment (n = 114) and death before 21 months after treatment (n = 137). WLWH were younger, were less wealthy, and had more estrogen receptor/progesterone receptor positive tumors. Overall, PCS and MCS significantly increased from treatment end to 24 months after treatment, from 50.8 to 52.8 and 51.8 to 53.7, respectively. There was no difference in the change of the PCS or MCS with HIV infection, 2.2 (95% CI, -0.4 to 4.9) and 0.6 (95% CI, -1.7 to 2.9), respectively.</p><p><strong>Conclusion: </strong>HIV infection did not impede QOL gain at 24 months after treatment in women surviving breast cancer. Further work is needed to clarify the role of HIV on specific treatment-related morbidities and in other malignancies.</p>","PeriodicalId":14806,"journal":{"name":"JCO Global Oncology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11315356/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141906628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors Associated With Survival Among Patients With Multiple Myeloma in Northeastern Tanzania. 坦桑尼亚东北部多发性骨髓瘤患者的生存相关因素。
IF 3.2 Q2 ONCOLOGY Pub Date : 2024-08-01 DOI: 10.1200/GO.24.00033
Faryal M Raza, Elifuraha W Mkwizu, Steven A Leak, Abid M Sadiq, Furaha S Lyamuya, Nyasatu G Chamba, Kajiru G Kilonzo, Elichilia R Shao, Eijaaz A Ahmed, Eliasa K Ndale, Andrew R Costantine, Eugenie M Kamabu, Doreen T Eliah, Eliada B Nziku, Oliver Henke

Purpose: This study sought to delineate the clinical, laboratory, and imaging characteristics during multiple myeloma (MM) diagnosis, outline the treatment modalities administered, and ascertain the survival rates among patients with MM over a comprehensive 5-year span in Tanzania.

Methods: This retrospective cohort study investigated patients diagnosed with MM at the Cancer Care Clinic, Kilimanjaro Christian Medical Centre, between January 2017 and June 2022. Demographic data, clinical profiles, and survival outcomes were collected. The study employed the Kaplan-Meier method to determine overall survival (OS) and survival rates, supported by univariate analysis and a multivariate Cox regression model with significance of P < .05.

Results: In this study of 76 patients with MM, bone pain was the most common complaint (76.3%), and patients were age typically older than 50 years (82.5%). Laboratory tests showed frequent abnormalities, such as anemia (51.3%) and hypercalcemia (23.9%). Most patients were at stage III according to Durie Salmon Staging (82.7%), with imaging revealing various bone abnormalities. The median OS was 18.0 months, with 46.1% of patients passing away during the study period. Factors linked to shorter survival included anemia, renal failure, and bone involvement. Infection was the primary cause of death among these patients. The presenting complaint of bone pain significantly affected survival outcomes.

Conclusion: This study provides a comprehensive understanding of MM within the Sub-Saharan African context, highlighting age-related disparities in diagnosis, predominant presenting symptoms like bone pain, factors contributing to delayed diagnoses, and the impact on survival rates. The findings underscore the critical need for early recognition, improved diagnostics, and tailored interventions to enhance outcomes for patients with MM in this region.

目的:本研究旨在描述坦桑尼亚多发性骨髓瘤(MM)诊断过程中的临床、实验室和影像学特征,概述所采用的治疗方法,并确定MM患者5年的生存率:这项回顾性队列研究调查了2017年1月至2022年6月期间在乞力马扎罗基督教医疗中心癌症护理诊所确诊的多发性骨髓瘤患者。研究收集了人口统计学数据、临床概况和生存结果。研究采用Kaplan-Meier法确定总生存期(OS)和生存率,并辅以单变量分析和多变量Cox回归模型,显著性P<.05:在这项对 76 名 MM 患者进行的研究中,骨痛是最常见的主诉(76.3%),患者的年龄一般在 50 岁以上(82.5%)。实验室检查经常出现异常现象,如贫血(51.3%)和高钙血症(23.9%)。根据 Durie Salmon 分期法,大多数患者处于 III 期(82.7%),影像学检查显示有各种骨质异常。中位生存期为18.0个月,46.1%的患者在研究期间去世。导致生存期缩短的因素包括贫血、肾功能衰竭和骨受累。感染是这些患者死亡的主要原因。骨痛的主诉对生存结果有很大影响:本研究提供了对撒哈拉以南非洲地区 MM 的全面了解,强调了与年龄相关的诊断差异、骨痛等主要表现症状、导致诊断延迟的因素以及对生存率的影响。研究结果突出表明,该地区亟需早期识别、改进诊断和有针对性的干预措施,以提高 MM 患者的治疗效果。
{"title":"Factors Associated With Survival Among Patients With Multiple Myeloma in Northeastern Tanzania.","authors":"Faryal M Raza, Elifuraha W Mkwizu, Steven A Leak, Abid M Sadiq, Furaha S Lyamuya, Nyasatu G Chamba, Kajiru G Kilonzo, Elichilia R Shao, Eijaaz A Ahmed, Eliasa K Ndale, Andrew R Costantine, Eugenie M Kamabu, Doreen T Eliah, Eliada B Nziku, Oliver Henke","doi":"10.1200/GO.24.00033","DOIUrl":"https://doi.org/10.1200/GO.24.00033","url":null,"abstract":"<p><strong>Purpose: </strong>This study sought to delineate the clinical, laboratory, and imaging characteristics during multiple myeloma (MM) diagnosis, outline the treatment modalities administered, and ascertain the survival rates among patients with MM over a comprehensive 5-year span in Tanzania.</p><p><strong>Methods: </strong>This retrospective cohort study investigated patients diagnosed with MM at the Cancer Care Clinic, Kilimanjaro Christian Medical Centre, between January 2017 and June 2022. Demographic data, clinical profiles, and survival outcomes were collected. The study employed the Kaplan-Meier method to determine overall survival (OS) and survival rates, supported by univariate analysis and a multivariate Cox regression model with significance of <i>P</i> < .05.</p><p><strong>Results: </strong>In this study of 76 patients with MM, bone pain was the most common complaint (76.3%), and patients were age typically older than 50 years (82.5%). Laboratory tests showed frequent abnormalities, such as anemia (51.3%) and hypercalcemia (23.9%). Most patients were at stage III according to Durie Salmon Staging (82.7%), with imaging revealing various bone abnormalities. The median OS was 18.0 months, with 46.1% of patients passing away during the study period. Factors linked to shorter survival included anemia, renal failure, and bone involvement. Infection was the primary cause of death among these patients. The presenting complaint of bone pain significantly affected survival outcomes.</p><p><strong>Conclusion: </strong>This study provides a comprehensive understanding of MM within the Sub-Saharan African context, highlighting age-related disparities in diagnosis, predominant presenting symptoms like bone pain, factors contributing to delayed diagnoses, and the impact on survival rates. The findings underscore the critical need for early recognition, improved diagnostics, and tailored interventions to enhance outcomes for patients with MM in this region.</p>","PeriodicalId":14806,"journal":{"name":"JCO Global Oncology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141906627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Financial Sequelae of Cancer for Patients' Family Members and Caregivers: A Focus on the Philippines. 癌症给患者家属和护理人员带来的经济后果:聚焦菲律宾。
IF 3.2 Q2 ONCOLOGY Pub Date : 2024-07-01 DOI: 10.1200/GO.24.00074
Rod Carlo Columbres, Erin Jay G Feliciano, Lance Isidore Catedral, Jose Ma H Zaldarriaga, Michelle Ann B Eala, Jerickson Abbie Flores, Enrico D Tangco, Narjust Florez, Frederic Ivan L Ting, Edward Christopher Dee
{"title":"Financial Sequelae of Cancer for Patients' Family Members and Caregivers: A Focus on the Philippines.","authors":"Rod Carlo Columbres, Erin Jay G Feliciano, Lance Isidore Catedral, Jose Ma H Zaldarriaga, Michelle Ann B Eala, Jerickson Abbie Flores, Enrico D Tangco, Narjust Florez, Frederic Ivan L Ting, Edward Christopher Dee","doi":"10.1200/GO.24.00074","DOIUrl":"https://doi.org/10.1200/GO.24.00074","url":null,"abstract":"","PeriodicalId":14806,"journal":{"name":"JCO Global Oncology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141590344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Collapse of Cancer Care Under the Current Conflict in Sudan. 苏丹当前冲突下癌症治疗的崩溃。
IF 3.2 Q2 ONCOLOGY Pub Date : 2024-07-01 DOI: 10.1200/GO.24.00144
Iman Ahmed, Moawia M A Elhassan, Khatir Elnour, Richard Sullivan, Nazik Hammad

Sudan has been under an armed conflict between the Sudanese Armed Forces and the Rapid Support Forces (RSF) militia since April 15, 2023. The conflict has turned the country into the largest internal displacement humanitarian crisis with 9.05 million internally displaced persons including 2.2 million children younger than 5 years and caused 1.47 million Sudanese to flee the country as refugees. The conflict has had a major destructive impact on the health system, which has incurred targeting with air raids, ground invasion, vandalization, looting of assets and supplies, and killing of doctors, nurses, and other health personnel. Khartoum Oncology Hospital, Sudan's main cancer hub for treatment, diagnostics, and research has become nonfunctional as a result of the conflict. The National Cancer Institute in Wad Medani, the second largest hub, faced a similar fate as the conflict spread to Al-Gezira State. Patients with cancer have been displaced multiple times in Sudan with grave consequences on the continuity of care, worsening of their disease outcomes and palpable negative impacts on children. The oncology workforce in Sudan have themselves been displaced yet are working hard to provide services and care for patients under impossible circumstances. Sudan's doctors in diaspora have rallied to provide support but they face multiple obstacles. As the conflict continues to spread, we call upon the WHO, the United Nations Children's Fund, St Jude Hospital, and all relevant partners to implement an immediate evacuation operation with urgent air lifts of the affected children to continue their cancer care in neighboring countries as was done in Ukraine and Gaza.

自 2023 年 4 月 15 日以来,苏丹一直处于苏丹武装部队和快速支援部队(RSF)民兵之间的武装冲突之中。这场冲突使苏丹陷入了最大的境内流离失所人道主义危机,造成 905 万境内流离失所者,其中包括 220 万 5 岁以下的儿童,并导致 147 万苏丹人作为难民逃离该国。冲突对卫生系统造成了严重的破坏性影响,空袭、地面入侵、破坏、掠夺资产和物资,以及杀害医生、护士和其他卫生人员,都使卫生系统成为攻击目标。喀土穆肿瘤医院是苏丹主要的癌症治疗、诊断和研究中心,冲突导致该医院无法运作。随着冲突蔓延到杰济拉州,位于瓦德迈达尼(Wad Medani)的国家癌症研究所(第二大中心)也面临着类似的命运。在苏丹,癌症患者多次流离失所,严重影响了治疗的连续性,导致病情恶化,并对儿童产生了明显的负面影响。苏丹的肿瘤工作者本身也流离失所,但他们仍在不可能的情况下努力工作,为患者提供服务和护理。散居国外的苏丹医生们团结起来提供支持,但他们面临着多重障碍。随着冲突的继续蔓延,我们呼吁世卫组织、联合国儿童基金会、圣裘德医院以及所有相关合作伙伴立即实施撤离行动,紧急空运受影响的儿童到邻国继续接受癌症治疗,就像在乌克兰和加沙所做的那样。
{"title":"Collapse of Cancer Care Under the Current Conflict in Sudan.","authors":"Iman Ahmed, Moawia M A Elhassan, Khatir Elnour, Richard Sullivan, Nazik Hammad","doi":"10.1200/GO.24.00144","DOIUrl":"10.1200/GO.24.00144","url":null,"abstract":"<p><p>Sudan has been under an armed conflict between the Sudanese Armed Forces and the Rapid Support Forces (RSF) militia since April 15, 2023. The conflict has turned the country into the largest internal displacement humanitarian crisis with 9.05 million internally displaced persons including 2.2 million children younger than 5 years and caused 1.47 million Sudanese to flee the country as refugees. The conflict has had a major destructive impact on the health system, which has incurred targeting with air raids, ground invasion, vandalization, looting of assets and supplies, and killing of doctors, nurses, and other health personnel. Khartoum Oncology Hospital, Sudan's main cancer hub for treatment, diagnostics, and research has become nonfunctional as a result of the conflict. The National Cancer Institute in Wad Medani, the second largest hub, faced a similar fate as the conflict spread to Al-Gezira State. Patients with cancer have been displaced multiple times in Sudan with grave consequences on the continuity of care, worsening of their disease outcomes and palpable negative impacts on children. The oncology workforce in Sudan have themselves been displaced yet are working hard to provide services and care for patients under impossible circumstances. Sudan's doctors in diaspora have rallied to provide support but they face multiple obstacles. As the conflict continues to spread, we call upon the WHO, the United Nations Children's Fund, St Jude Hospital, and all relevant partners to implement an immediate evacuation operation with urgent air lifts of the affected children to continue their cancer care in neighboring countries as was done in Ukraine and Gaza.</p>","PeriodicalId":14806,"journal":{"name":"JCO Global Oncology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141498114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oncoplastic Breast-Conserving Surgery in African Women: A Systematic Review. 非洲妇女的肿瘤整形保乳手术:系统回顾
IF 3.2 Q2 ONCOLOGY Pub Date : 2024-07-01 DOI: 10.1200/GO.23.00460
Abdulhafiz Oladapo Adesunkanmi, Funmilola Olanike Wuraola, Oluwatobiloba Michael Fagbayimu, Murtuza Aliasger Calcuttawala, Tajudeen Wahab, Adewale Oluseye Adisa

Purpose: Breast cancer is the most frequently diagnosed cancer in women worldwide. Surgery is a major treatment modality for breast cancer, and over the years, breast-conserving surgeries with breast radiation have shown similar outcomes with mastectomy. Not much is known about the frequency and outcome of breast-conserving surgery in Africa. This systematic review provides a comprehensive summary of the evidence evaluating cosmetic and oncologic outcomes after oncoplastic breast-conserving surgery (OBCS) for breast cancer in African women.

Methods: This review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. Databases were systematically searched for studies on African women undergoing OBCS. The oncologic and cosmetic outcomes, as well as the localization and reconstruction techniques, were evaluated. Descriptive statistics were used to summarize the frequency and proportions of the extracted variables.

Results: The literature search yielded 266 articles but only 26 of these were included in the review. Majority of the studies were from Egypt and South Africa. These studies collectively evaluated 1,896 patients with a mean age of 48.2 years and a mean follow-up period of 36.9 months. The most common histopathology was T2 (71.4%) invasive ductal carcinoma. Hook wire localization was the most common technique used for nonpalpable lesions in 85.3% of patients. Of the studies reporting oncoplastic technique, the latissimus dorsi volume replacement technique was the most reported (15%). Most patients were satisfied with their cosmetic outcome. Seroma was the most common postoperative complication (44.6%). Among studies that reported oncologic outcome data, the crude overall survival and disease-free survival were 93.1% and 89.4%, respectively.

Conclusion: This systematic review revealed that the outcome of OBCS in African women compares with that in developed countries.

目的:乳腺癌是全球妇女最常确诊的癌症。手术是治疗乳腺癌的主要方法,多年来,保乳手术和乳房放射治疗的效果与乳房切除术相似。但人们对非洲保乳手术的频率和效果知之甚少。本系统性综述全面总结了非洲女性接受肿瘤整形保乳手术(OBCS)后的美容和肿瘤治疗效果的评估证据:本综述根据《系统综述和元分析首选报告项目》声明进行。我们在数据库中系统地搜索了有关非洲女性接受 OBCS 的研究。对肿瘤和美容效果以及定位和重建技术进行了评估。结果:文献检索共获得 266 篇文章,但其中只有 26 篇被纳入综述。大部分研究来自埃及和南非。这些研究共评估了 1,896 名患者,平均年龄为 48.2 岁,平均随访时间为 36.9 个月。最常见的组织病理学是 T2(71.4%)浸润性导管癌。钩丝定位是用于非肉眼可见病变的最常用技术,占 85.3%。在报道肿瘤整形技术的研究中,背阔肌体积置换技术的报道最多(15%)。大多数患者对美容效果感到满意。血清肿是最常见的术后并发症(44.6%)。在报告了肿瘤结果数据的研究中,粗略的总生存率和无病生存率分别为93.1%和89.4%:这项系统性综述显示,非洲妇女的 OBCS 结果与发达国家的结果相当。
{"title":"Oncoplastic Breast-Conserving Surgery in African Women: A Systematic Review.","authors":"Abdulhafiz Oladapo Adesunkanmi, Funmilola Olanike Wuraola, Oluwatobiloba Michael Fagbayimu, Murtuza Aliasger Calcuttawala, Tajudeen Wahab, Adewale Oluseye Adisa","doi":"10.1200/GO.23.00460","DOIUrl":"https://doi.org/10.1200/GO.23.00460","url":null,"abstract":"<p><strong>Purpose: </strong>Breast cancer is the most frequently diagnosed cancer in women worldwide. Surgery is a major treatment modality for breast cancer, and over the years, breast-conserving surgeries with breast radiation have shown similar outcomes with mastectomy. Not much is known about the frequency and outcome of breast-conserving surgery in Africa. This systematic review provides a comprehensive summary of the evidence evaluating cosmetic and oncologic outcomes after oncoplastic breast-conserving surgery (OBCS) for breast cancer in African women.</p><p><strong>Methods: </strong>This review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. Databases were systematically searched for studies on African women undergoing OBCS. The oncologic and cosmetic outcomes, as well as the localization and reconstruction techniques, were evaluated. Descriptive statistics were used to summarize the frequency and proportions of the extracted variables.</p><p><strong>Results: </strong>The literature search yielded 266 articles but only 26 of these were included in the review. Majority of the studies were from Egypt and South Africa. These studies collectively evaluated 1,896 patients with a mean age of 48.2 years and a mean follow-up period of 36.9 months. The most common histopathology was T2 (71.4%) invasive ductal carcinoma. Hook wire localization was the most common technique used for nonpalpable lesions in 85.3% of patients. Of the studies reporting oncoplastic technique, the latissimus dorsi volume replacement technique was the most reported (15%). Most patients were satisfied with their cosmetic outcome. Seroma was the most common postoperative complication (44.6%). Among studies that reported oncologic outcome data, the crude overall survival and disease-free survival were 93.1% and 89.4%, respectively.</p><p><strong>Conclusion: </strong>This systematic review revealed that the outcome of OBCS in African women compares with that in developed countries.</p>","PeriodicalId":14806,"journal":{"name":"JCO Global Oncology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141758770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metabolic Reprogramming and Extracranial Solid Tumor Evolution in Infants 婴儿代谢重编程与颅外实体瘤演变
IF 3.2 Q2 ONCOLOGY Pub Date : 2024-07-01 DOI: 10.1200/go-24-98000
Poorvi Subramanian, Natarajan Aravindan
Disease progression after intensive multi modal clinical therapy poses grave concern not only on the quality of life but on the very survival of children presented with neuroblastoma. Acquired modifications of energy metabolism in the tumor cells that defy clinical therapy plays pivotal role in frequent and rapid tumor relapse. We investigated the mechanisms of how these cells adopt metabolic rearrangements with therapy pressure. Our earlier findings showed the constitutive availability of retinal degeneration protein 3 (RD3) in human fetal tissues beyond retina, displayed its functional role in tumor pathogenesis, and unearthed its significance in neuroblastoma clinical outcomes. Herein, with the gene surrogate strategy, the whole genome RNA sequencing in reverse engineered (bed-to-bench) patient derived cell lines showed a patient-independent, RD3-dependent stabilization of metabolic programming. Loss of RD3 altered crucial metabolic pathways and coordinated metabolic mayhem in high-risk stage-4 disease. Evaluating the glycolysis phenotype with seahorse revealed that RD3 loss dependent increase in extracellular acidification rate (EACR) associated with glycolysis, glycolytic capacity and glycolytic reserves in therapy defying progressive disease. Critically, therapeutic delivery of RD3 (custom archived and characterized RD3 peptide candidates) significantly deregulated glycolysis in such progressive disease that lack RD3, recognizing a RD3-dependent regulation of metabolic activity. Our study outcomes clearly portrayed the thus far unrealized significance of therapy pressure driven RD3 loss mediated metabolism deregulation in neuroblastoma. Crucially, these new findings will pave way for the identification of a novel targeted maintenance therapeutic strategy for treatment of this deadly disease.
神经母细胞瘤患儿在接受多种模式的强化临床治疗后,病情仍在发展,这不仅严重影响了患儿的生活质量,也影响了患儿的生存。肿瘤细胞的后天能量代谢改变无法抵御临床治疗,这在肿瘤频繁快速复发中起着关键作用。我们研究了这些细胞如何在治疗压力下进行代谢重排的机制。我们早先的研究结果表明,视网膜变性蛋白 3(RD3)在人类胎儿视网膜以外的组织中存在,显示了其在肿瘤发病机制中的功能性作用,并揭示了其在神经母细胞瘤临床结局中的重要意义。在这里,利用基因替代策略,对逆向工程(从床上到床上)患者衍生细胞系进行全基因组 RNA 测序,结果显示代谢程序的稳定与患者无关,但依赖于 RD3。RD3 的缺失改变了关键的代谢途径,并协调了高风险的 4 期疾病中的代谢混乱。用海马评估糖酵解表型发现,细胞外酸化率(EACR)的增加与糖酵解、糖酵解能力和糖酵解储备有关,而糖酵解能力和糖酵解储备的增加依赖于糖酵解能力的增加。重要的是,在缺乏 RD3 的进展性疾病中,RD3(定制归档和特征化的 RD3 肽候选物)的治疗给药显著降低了糖酵解,从而确认了代谢活动的调节依赖于 RD3。我们的研究成果清楚地描绘了治疗压力驱动的 RD3 缺失介导的神经母细胞瘤代谢失调迄今尚未实现的意义。至关重要的是,这些新发现将为确定治疗这种致命疾病的新型靶向维持治疗策略铺平道路。
{"title":"Metabolic Reprogramming and Extracranial Solid Tumor Evolution in Infants","authors":"Poorvi Subramanian, Natarajan Aravindan","doi":"10.1200/go-24-98000","DOIUrl":"https://doi.org/10.1200/go-24-98000","url":null,"abstract":"Disease progression after intensive multi modal clinical therapy poses grave concern not only on the quality of life but on the very survival of children presented with neuroblastoma. Acquired modifications of energy metabolism in the tumor cells that defy clinical therapy plays pivotal role in frequent and rapid tumor relapse. We investigated the mechanisms of how these cells adopt metabolic rearrangements with therapy pressure. Our earlier findings showed the constitutive availability of retinal degeneration protein 3 (RD3) in human fetal tissues beyond retina, displayed its functional role in tumor pathogenesis, and unearthed its significance in neuroblastoma clinical outcomes. Herein, with the gene surrogate strategy, the whole genome RNA sequencing in reverse engineered (bed-to-bench) patient derived cell lines showed a patient-independent, RD3-dependent stabilization of metabolic programming. Loss of RD3 altered crucial metabolic pathways and coordinated metabolic mayhem in high-risk stage-4 disease. Evaluating the glycolysis phenotype with seahorse revealed that RD3 loss dependent increase in extracellular acidification rate (EACR) associated with glycolysis, glycolytic capacity and glycolytic reserves in therapy defying progressive disease. Critically, therapeutic delivery of RD3 (custom archived and characterized RD3 peptide candidates) significantly deregulated glycolysis in such progressive disease that lack RD3, recognizing a RD3-dependent regulation of metabolic activity. Our study outcomes clearly portrayed the thus far unrealized significance of therapy pressure driven RD3 loss mediated metabolism deregulation in neuroblastoma. Crucially, these new findings will pave way for the identification of a novel targeted maintenance therapeutic strategy for treatment of this deadly disease.","PeriodicalId":14806,"journal":{"name":"JCO Global Oncology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141838638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiological Analysis of Deaths for Malignant Bladder Neoplasia in Adults in the Last 4 Years in Brazilian Territory 过去 4 年巴西成人因恶性膀胱肿瘤死亡的流行病学分析
IF 3.2 Q2 ONCOLOGY Pub Date : 2024-07-01 DOI: 10.1200/go-24-56000
Y. Loureiro, Guihherme Ferreira Cruz, Eduarda Paica Borsa, Heitor Vieira Rodrigues, Pedro Henrique Paesi Dutra
Bladder cancer represents a significant public health concern worldwide, with its incidence and socioeconomic impact standing out as persistent challenges. The objectives of this study were to analyze deaths related to malignant bladder neoplasms in Brazil between 2019 and 2022, conducting an analysis in relation to the age group, sex, and color/race of the patients, with the aim of providing an overview of mortality during this period. This is a cross-sectional, retrospective, descriptive study about deaths related to malignant bladder neoplasms in Brazil from 2019 to 2022. The data were gathered from the Brazilian Unified Health System (DATASUS) in the “Tabnet” section, selecting those that addressed the age group, sex, and color/race of the patient. The information was grouped in the four years in question based on the three variables mentioned and subsequently analyzed to establish an overview of mortality in the period. The period and detailed age group accounted for a total of 10,073 deaths in Brazil. The highest number of deaths occurred in 2022 (26.92%), followed by 2021 (25.68%). There was an increase in total prevalence during the studied period, with the highest rate of increase between the years 2020 and 2021 (6.54%), followed by 4.83% between the years 2021-2022. Comparing 2019 with 2022, there was an increase of 15.60%, with the number of deaths in 2022 equivalent to 26.92% of the entire period studied. There were more deaths among male patients, with more than a 100% difference in prevalence between sexes throughout the entire period. The Caucasian population was the most affected, corresponding to 64.57% of deaths during this period. Therefore, it is possible to understand, based on the epidemiological profile constructed, how deaths related to malignant bladder neoplasms in adults have been established in recent years. Thus, it is noted that mortality has increased, emphasizing the relevance of the problem. It was also possible to outline the most prevalent patient profile, which corresponds to male and Caucasian patients. Therefore, the broad development of measures to mitigate this alarming public health problem becomes relevant in Brazil.
膀胱癌是全球关注的重大公共卫生问题,其发病率和社会经济影响是长期存在的挑战。本研究的目的是分析 2019 年至 2022 年期间巴西与恶性膀胱肿瘤相关的死亡病例,根据患者的年龄组、性别和肤色/种族进行分析,旨在提供这一时期的死亡率概况。这是一项横断面、回顾性、描述性研究,涉及 2019 年至 2022 年巴西与恶性膀胱肿瘤相关的死亡病例。数据收集自巴西统一卫生系统(DATASUS)的 "Tabnet "部分,选择涉及患者年龄组、性别和肤色/种族的数据。根据上述三个变量将信息按四年进行分组,然后进行分析,以确定这一时期的死亡率概况。在这一时期和详细的年龄组中,巴西共有 10,073 人死亡。死亡人数最多的是 2022 年(26.92%),其次是 2021 年(25.68%)。在研究期间,总发病率有所上升,其中 2020 年至 2021 年的增长率最高(6.54%),其次是 2021 年至 2022 年的 4.83%。2019 年与 2022 年相比,死亡人数增加了 15.60%,2022 年的死亡人数相当于整个研究期间的 26.92%。男性患者的死亡人数较多,在整个研究期间,男女发病率相差超过 100%。白种人受影响最大,占这一时期死亡人数的 64.57%。因此,根据所构建的流行病学概况,我们可以了解近年来与成人恶性膀胱肿瘤相关的死亡是如何形成的。因此,我们注意到死亡率有所上升,从而强调了这一问题的相关性。此外,还可以勾勒出最常见的患者特征,即男性和白种人。因此,在巴西,广泛制定措施来缓解这一令人担忧的公共卫生问题具有现实意义。
{"title":"Epidemiological Analysis of Deaths for Malignant Bladder Neoplasia in Adults in the Last 4 Years in Brazilian Territory","authors":"Y. Loureiro, Guihherme Ferreira Cruz, Eduarda Paica Borsa, Heitor Vieira Rodrigues, Pedro Henrique Paesi Dutra","doi":"10.1200/go-24-56000","DOIUrl":"https://doi.org/10.1200/go-24-56000","url":null,"abstract":"Bladder cancer represents a significant public health concern worldwide, with its incidence and socioeconomic impact standing out as persistent challenges. The objectives of this study were to analyze deaths related to malignant bladder neoplasms in Brazil between 2019 and 2022, conducting an analysis in relation to the age group, sex, and color/race of the patients, with the aim of providing an overview of mortality during this period. This is a cross-sectional, retrospective, descriptive study about deaths related to malignant bladder neoplasms in Brazil from 2019 to 2022. The data were gathered from the Brazilian Unified Health System (DATASUS) in the “Tabnet” section, selecting those that addressed the age group, sex, and color/race of the patient. The information was grouped in the four years in question based on the three variables mentioned and subsequently analyzed to establish an overview of mortality in the period. The period and detailed age group accounted for a total of 10,073 deaths in Brazil. The highest number of deaths occurred in 2022 (26.92%), followed by 2021 (25.68%). There was an increase in total prevalence during the studied period, with the highest rate of increase between the years 2020 and 2021 (6.54%), followed by 4.83% between the years 2021-2022. Comparing 2019 with 2022, there was an increase of 15.60%, with the number of deaths in 2022 equivalent to 26.92% of the entire period studied. There were more deaths among male patients, with more than a 100% difference in prevalence between sexes throughout the entire period. The Caucasian population was the most affected, corresponding to 64.57% of deaths during this period. Therefore, it is possible to understand, based on the epidemiological profile constructed, how deaths related to malignant bladder neoplasms in adults have been established in recent years. Thus, it is noted that mortality has increased, emphasizing the relevance of the problem. It was also possible to outline the most prevalent patient profile, which corresponds to male and Caucasian patients. Therefore, the broad development of measures to mitigate this alarming public health problem becomes relevant in Brazil.","PeriodicalId":14806,"journal":{"name":"JCO Global Oncology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141841532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Collaborative Action for Public Health: The Esophageal Cancer Consortium's Approach to Policy Influence and Capturing Policy Makers' Attention in Ethiopia 公共卫生合作行动:食管癌联合会在埃塞俄比亚影响政策和吸引决策者注意力的方法
IF 3.2 Q2 ONCOLOGY Pub Date : 2024-07-01 DOI: 10.1200/go-24-39000
B. T. Deressa, Haji Aman Deybasso, Abebe Megerso, Jibril Bashir Adem, Dagim Tekeba, M. Mama, Didha Batu, Bonso Bude, Gebi Agero, Gudeta Hinika, Ismael Tura, Mohammed Kabeto, Abdella Amano Abdo, Desalegn Fikadu, Abashamo Lencho, Melik Tiba
Esophageal cancer disproportionately affects specific regions in Ethiopia, particularly the Arsi Bale areas. 1 , 2 Studies reveal that more than 50% of esophageal cancer cases in Ethiopia originate from Arsi-Bale region. 3 Collaborative efforts by individuals and institutions from this region-initiated actions to elevate esophageal cancer as a national concern. This abstract illustrates the collaborative process and the formation of the Esophageal Cancer Consortium in Ethiopia. The method encompasses collaborative discussions, real-time documentation during detailed dialogues, and iterative reviews aimed at capturing the program's evolution and key achievements. Experts from clinical and public health fields, actively involved throughout the program's lifecycle, contributed insights from its inception to its current state. Initiatives to prioritize esophageal cancer as a public health concern in Arsi-Bale regions were spearheaded by individuals and diasporas from these regions. These efforts led to the first conference at Arsi University in 2022, involving clinicians, researchers, public figures, and community leaders, along with four educational institutions, namely Arsi University, Madda Wallabu University, Adama Hospital Medical College, and Arsi Negelle General Hospital and Medical College, and International Oromo Health Professional Association (IOHPA). This conference resulted in forming the Southeast Esophageal Cancer Task Force (SEECTF). Progressive efforts, including regular weekly meetings under the structured SEECTF, led to the implementation of a first-of-its-kind endoscopy curriculum in Ethiopia, initiation of endoscopy diagnosis in previously unequipped hospitals, and the development of the first Esophageal cancer treatment guidelines and training manuals in Ethiopia. Community education pamphlets in local languages and community education through mass media were implemented. During the second national esophageal cancer conference in 2023, which led to national recognition, MOUs were signed with the Ministry of Health, Oromia Regional Health Bureau, the four educational institutions, and IOHPA. This conference resulted in the formation of a centralized consortium involving these institutions under one umbrella, working on research, advocacy, and capacity building, channeling esophageal cancer actions nationally. Collaborative efforts by individuals and institutions are crucial in influencing policymakers, addressing public health concerns, and garnering national attention and action to reduce the burden of esophageal cancer and enhance patients' quality of life in Ethiopia.
食管癌对埃塞俄比亚特定地区的影响尤为严重,尤其是阿尔西-巴莱地区。1 , 2 研究显示,埃塞俄比亚 50%以上的食管癌病例来自阿尔西-巴莱地区。3 该地区的个人和机构共同努力,将食管癌提升为国家关注的问题。本摘要介绍了埃塞俄比亚食管癌联合会的合作过程和成立过程。该方法包括合作讨论、详细对话过程中的实时记录以及反复审查,旨在记录计划的演变和主要成就。来自临床和公共卫生领域的专家积极参与了该计划的整个生命周期,并对该计划从开始到目前的状况发表了自己的见解。来自阿尔西-巴莱地区的个人和侨民率先发起倡议,将食道癌作为这些地区的公共卫生问题列为优先事项。这些努力促成了 2022 年在阿尔西大学举行的第一次会议,与会者包括临床医生、研究人员、公众人物和社区领袖,以及四所教育机构,即阿尔西大学、马达瓦拉布大学、阿达玛医院医学院、阿尔西内盖勒综合医院和医学院,以及国际奥罗莫卫生专业协会(IOHPA)。这次会议的成果是成立了东南食道癌特别工作组(SEECTF)。通过不断努力,包括在结构化的东南食管癌工作组下每周定期举行会议,实施了埃塞俄比亚首创的内窥镜检查课程,在以前没有设备的医院启动了内窥镜检查诊断,并制定了埃塞俄比亚首份食管癌治疗指南和培训手册。用当地语言编写了社区教育小册子,并通过大众媒体开展社区教育。在 2023 年举行的第二次全国食道癌会议期间,与卫生部、奥罗莫地区卫生局、四家教育机构和国际食道癌协会签署了谅解备忘录,从而获得了国家认可。这次会议的成果是形成了一个集中的联合体,将这些机构纳入一个保护伞下,致力于研究、宣传和能力建设,在全国范围内开展食管癌行动。个人和机构的共同努力对于影响政策制定者、解决公共卫生问题、吸引国家关注并采取行动以减轻食管癌负担和提高埃塞俄比亚患者的生活质量至关重要。
{"title":"Collaborative Action for Public Health: The Esophageal Cancer Consortium's Approach to Policy Influence and Capturing Policy Makers' Attention in Ethiopia","authors":"B. T. Deressa, Haji Aman Deybasso, Abebe Megerso, Jibril Bashir Adem, Dagim Tekeba, M. Mama, Didha Batu, Bonso Bude, Gebi Agero, Gudeta Hinika, Ismael Tura, Mohammed Kabeto, Abdella Amano Abdo, Desalegn Fikadu, Abashamo Lencho, Melik Tiba","doi":"10.1200/go-24-39000","DOIUrl":"https://doi.org/10.1200/go-24-39000","url":null,"abstract":"Esophageal cancer disproportionately affects specific regions in Ethiopia, particularly the Arsi Bale areas. 1 , 2 Studies reveal that more than 50% of esophageal cancer cases in Ethiopia originate from Arsi-Bale region. 3 Collaborative efforts by individuals and institutions from this region-initiated actions to elevate esophageal cancer as a national concern. This abstract illustrates the collaborative process and the formation of the Esophageal Cancer Consortium in Ethiopia. The method encompasses collaborative discussions, real-time documentation during detailed dialogues, and iterative reviews aimed at capturing the program's evolution and key achievements. Experts from clinical and public health fields, actively involved throughout the program's lifecycle, contributed insights from its inception to its current state. Initiatives to prioritize esophageal cancer as a public health concern in Arsi-Bale regions were spearheaded by individuals and diasporas from these regions. These efforts led to the first conference at Arsi University in 2022, involving clinicians, researchers, public figures, and community leaders, along with four educational institutions, namely Arsi University, Madda Wallabu University, Adama Hospital Medical College, and Arsi Negelle General Hospital and Medical College, and International Oromo Health Professional Association (IOHPA). This conference resulted in forming the Southeast Esophageal Cancer Task Force (SEECTF). Progressive efforts, including regular weekly meetings under the structured SEECTF, led to the implementation of a first-of-its-kind endoscopy curriculum in Ethiopia, initiation of endoscopy diagnosis in previously unequipped hospitals, and the development of the first Esophageal cancer treatment guidelines and training manuals in Ethiopia. Community education pamphlets in local languages and community education through mass media were implemented. During the second national esophageal cancer conference in 2023, which led to national recognition, MOUs were signed with the Ministry of Health, Oromia Regional Health Bureau, the four educational institutions, and IOHPA. This conference resulted in the formation of a centralized consortium involving these institutions under one umbrella, working on research, advocacy, and capacity building, channeling esophageal cancer actions nationally. Collaborative efforts by individuals and institutions are crucial in influencing policymakers, addressing public health concerns, and garnering national attention and action to reduce the burden of esophageal cancer and enhance patients' quality of life in Ethiopia.","PeriodicalId":14806,"journal":{"name":"JCO Global Oncology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141841860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
JCO Global Oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1